- Home
- RNAZ vs MSGM Comparison
RNAZ vs MSGM Comparison
Compare RNAZ & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- MSGM
- Stock Information
- Founded
- RNAZ 2016
- MSGM 2018
- Country
- RNAZ United States
- MSGM United States
- Employees
- RNAZ N/A
- MSGM N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- MSGM Computer Software: Prepackaged Software
- Sector
- RNAZ Health Care
- MSGM Technology
- Exchange
- RNAZ Nasdaq
- MSGM Nasdaq
- Market Cap
- RNAZ 4.9M
- MSGM 4.5M
- IPO Year
- RNAZ 2021
- MSGM 2021
- Fundamental
- Price
- RNAZ $3.35
- MSGM $1.37
- Analyst Decision
- RNAZ Strong Buy
- MSGM Hold
- Analyst Count
- RNAZ 1
- MSGM 1
- Target Price
- RNAZ $20.00
- MSGM $5.00
- AVG Volume (30 Days)
- RNAZ 143.7K
- MSGM 46.9K
- Earning Date
- RNAZ 11-14-2024
- MSGM 11-14-2024
- Dividend Yield
- RNAZ N/A
- MSGM N/A
- EPS Growth
- RNAZ N/A
- MSGM N/A
- EPS
- RNAZ N/A
- MSGM 1.84
- Revenue
- RNAZ N/A
- MSGM $8,460,953.00
- Revenue This Year
- RNAZ N/A
- MSGM $23.00
- Revenue Next Year
- RNAZ N/A
- MSGM $72.82
- P/E Ratio
- RNAZ N/A
- MSGM $0.74
- Revenue Growth
- RNAZ N/A
- MSGM N/A
- 52 Week Low
- RNAZ $2.66
- MSGM $1.01
- 52 Week High
- RNAZ $66.33
- MSGM $4.16
- Technical
- Relative Strength Index (RSI)
- RNAZ 30.32
- MSGM 55.63
- Support Level
- RNAZ $2.90
- MSGM $1.24
- Resistance Level
- RNAZ $3.50
- MSGM $1.49
- Average True Range (ATR)
- RNAZ 0.42
- MSGM 0.13
- MACD
- RNAZ 0.31
- MSGM 0.00
- Stochastic Oscillator
- RNAZ 50.74
- MSGM 46.15
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.